Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Visit One News Page for Australia news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Australia news headlines.

older | 1 | .... | 1393 | 1394 | (Page 1395) | 1396 | 1397 | .... | 1460 | newer

    0 0

    Here’s what you need to know to start your day. Reported by NYTimes.com 11 minutes ago.

    0 0

    The Newcastle duo met before Declan Donnelly was set to jet out to Australia for I'm A Celebrity... Get Me Out Of Here. Reported by Daily Record 1 hour ago.

    0 0

    Sigma Foundation for Nursing funding contributes to evidence-based nursing research and practice.

    INDIANAPOLIS (PRWEB) November 08, 2018

    The Sigma Theta Tau International Honor Society of Nursing (Sigma) recently announced recipients of the following nursing research grants awarded in 2018. These grants were made possible by the Sigma Foundation for Nursing, funding partners, and individual contributors to the Foundation’s research fund.

    APRIL GRANT RECIPIENTS

    Sigma/Hospice and Palliative Nurses Foundation End-of-Life Nursing Care Research Grant
    Teaching Caregivers of Hospice Patients to Administer Reiki for Symptom Management and Caregiver Self-Care: A Feasibility Pilot Study
    Susan E. Thrane PhD, MSN, RN, CHPN
    The Ohio State University
    Grant Impact: Learning and providing Reiki – which has been shown to be helpful with symptoms such as pain, anxiety, depression, and fatigue – may give caregivers a way to help their loved one with symptoms while at the same time feeling useful. Knowledge gained from this study will guide future interventions aimed at the comfort of hospice patients, family caregivers, and hospice volunteers.

    Sigma/Midwest Nursing Research Society Research Grant
    Lifestyle Behavior Change Using Mobile Health (mHealth) Technology: A Grounded Theory Study of Breast Cancer Survivors
    Marjorie Kelley, MSN
    The Ohio State University
    Grant Impact: This research begins to investigate the integration of lifestyle modifications and behavior of app use in breast cancer survivors and will offer a substantive theory to build and design future mHealth interventions for lifestyle modification in cancer survivors. It aligns with national research agendas promoting innovation through technology use to improve and personalize health advanced by the Oncology Nurses Society (ONS) and the National Institute of Nursing Research (NINR).

    Sigma/Southern Nursing Research Society Grant
    Vitamin C Supplementation Intervention for Patients with Heart Failure—A Pilot Study
    Jia-Rong Wu, PhD, MSN
    University of North Carolina at Chapel Hill, School of Nursing
    Grant Impact: The intervention study offers the opportunity to compare a vitamin C supplementation intervention testing two commonly used doses of vitamin C supplementation on heart failure symptoms and health-related quality of life as well as biomarkers of oxidative stress and cardiac function. Findings from this pilot project will support future tests of the efficacy of vitamin C supplementation in endothelial function, oxidative stress, heart failure symptoms, and improving health outcomes.

    MAY GRANT RECIPIENTS

    Sigma/American Nurses' Foundation Grant
    Motivational Interviewing for Cancer Pain Goals
    Olga Ehrlich PhD, BSN
    Dana-Farber Cancer Institute
    Grant Impact: This study will yield important new data about functional pain goal assessment in persons with cancer pain, an area of nursing practice and research that stands to contribute significantly to the reduction of overall high rates of poorly-controlled cancer pain. Results of this study will contribute data and knowledge so nurses can use motivational interviewing to help patients identify goals and develop related interventions for improving pain severity outcomes.

    Sigma/Chamberlain University College of Nursing Education Research Grant
    Health Belief Model Factors as Predictors of Parental Misclassification of the Weight of the Preschool Child
    Tanna Woods MSN, BSN
    Idaho State University
    Grant Impact: This research addresses parental misclassification of their child’s weight and ability to realize when weight becomes a problem. It will examine components of the health belief model (HBM) and assessing their relationship to parental misclassification. The time period of 2- to 5-year-olds is critical in future obesity and health problems and a time when behavioral modification can lead to improved outcomes.

    Sigma/Chamberlain University College of Nursing Education Research Grant
    CRiticAL Clinical Reasoning and simulation: the passive observer becomes Active Learner
    Naomi Tutticci, PhD, BN
    Queensland University of Technology-Nursing
    Grant Impact: This project focuses on enhancing learning in transformative ways. Students, who were not previously engaged in learning experiences within their simulation experience, will in future be able to articulate and practice key ‘real world’ attributes within their professional practice. Nursing students transitioning into the workforce are required to be workforce ready, with minimal time to transition into the professional role.

    Sigma Global Nursing Research Grant
    A Qualitative Exploration of Peer Mentoring after Spinal Cord Injury in Delhi, India
    Susan D. Newman PhD, BSN
    Medical University of South Carolina College of Nursing
    Grant Impact: This study will be the first known investigation on the experience of peer-mentoring to support health and community participation after spinal cord injury (SCI) in India. Peer mentoring is one potential strategy to extend the goals of rehabilitation, and more specifically rehabilitation nursing, into underserved communities. Findings of this study can inform innovative approaches to community-based SCI rehabilitation, especially in the context of low- to middle-income countries.

    JULY GRANT RECIPIENTS

    Doris Bloch Research Award
    Foot Self-care in Older Adults Without Diabetes
    Jennifer O’ Connor MS, BSN
    Sinclair School of Nursing, University of Missouri
    Grant Impact: Foot care self-management programs have been shown effective in improving foot health, knowledge, self-efficacy and self-care behaviors in persons with diabetes mellitus. Improved foot self-care among non-diabetic older adults may similarly help to minimize foot problems and related complications, maximize mobility and quality of life, and maintain independence in the growing older adult population.

    Joan K. Stout, RN, Research Grant
    Comparison of Simulation Exposure in Undergraduate Nursing Education and its Effect on Critical Thinking Development
    Joanne Knoesel, PhD, MSN
    Pace University
    Grant Impact: The findings from this study may provide insight into the relationship between simulation learning and critical thinking and evidence to current nursing programs for the ratio of simulation substitution in undergraduate nursing programs. The study may also provide meaningful learning experiences in the education of nursing students that can impact learning outcomes and can affect patient safety in the future.

    ATI Educational Assessment Nursing Research Grant
    Using Simulation to Develop Clinical Teaching Competencies in Nurse Educators
    Julie Fitzwater, MNE, BSN
    Linfield College
    Grant Impact: This proposed pilot study will further the quantitative evidence to promote the use of competency outcomes in simulation education of nurse educators. Further reliability of the instruments used will add to the knowledge in the field. As the competency outcomes are measured from simulation education, the next steps will be to measure the impacts on student outcomes and patient and system outcomes.

    American Nurses Credentialing Center Evidence-Based Practice Implementation Grant
    This grant is made possible with the support of Hill-Rom.
    Development, Implementation and Evaluation of an Evidence-Based Nurse-Led Rapid Response Program in a Low-Resource Setting
    Vinciya Pandian, PhD, MBA, MSN, RN, ACNP-BC, FAAN
    Johns Hopkins School of Nursing
    Grant Impact: This study uses simulation technology to provide training on different cardiac arrest resuscitation algorithms and mock rapid response teams, providing practical ways to engage interprofessional teams and build team dynamics and effective communication. Nurses in low-resource settings will be educated on early warning signs; empowered to take the lead in identifying, communicating, and intervening in a timely manner; provide critical care in non-ICU wards; and decrease the number of cardiopulmonary arrests.

    About Sigma
    The Sigma Theta Tau International Honor Society of Nursing (Sigma) is a nonprofit organization whose mission is advancing world health and celebrating nursing excellence in scholarship, leadership, and service. Founded in 1922, Sigma has more than 135,000 active members in over 90 countries and territories. Members include practicing nurses, instructors, researchers, policymakers, entrepreneurs, and others. Sigma’s more than 530 chapters are located at more than 700 institutions of higher education throughout Armenia, Australia, Botswana, Brazil, Canada, Colombia, England, Ghana, Hong Kong, Japan, Jordan, Kenya, Lebanon, Malawi, Mexico, the Netherlands, Pakistan, Philippines, Portugal, Singapore, South Africa, South Korea, Swaziland, Sweden, Taiwan, Tanzania, Thailand, the United States, and Wales. Learn more at http://www.sigmanursing.org. Reported by PRWeb 1 hour ago.

    0 0

    Analysts at Westpac explained that the Fed held steady but sounded optimistic once again, setting up a December rate rise. 

    *Key Quotes:*

    "This was fully expected yet the US dollar rose across the board and equities faltered. Oil prices fell again to near 3 month lows."

    "Today's calendar includes the RBA's Statement on Monetary Policy, Australia Sep housing finance, China Oct CPI and UK Q3 GDP."

    "The Fed voted unanimously to leave interest rates steady, their statement including just a couple minor edits and overall continuing to acknowledge the robust economy and more gradual rate increases. Business investment was characterised as having, "moderated from its rapid pace earlier this year", a downgrade from "grown strongly", otherwise the Fed continues to note brisk conditions, repeatedly using “strong” to characterise  the labour market, household spending and broader activity. The Fed provided no explicit signal for a December hike but that's not necessary with markets almost fully pricing one in.
    EUR/USD fell from 1.1445 to 1.1365, having been 1.1400 pre-FOMC. Earlier, European Commission (EC) economic forecasts garnered more interest than normal (markets normally focus on ECB’s projections which are due in December) because of the scrutiny of Italy’s budget proposals. EC edged lower their growth for 2019 to 1.9% (still above ECB’s 1.8%) but the most important were the projections of Italy.  The EC forecast lower growth than the Italian government in coming years and so they project budget deficit to GDP of -2.9% in 2019 and -3.1% in 2020.

    USD/JPY rose from 113.60 to 114.00 – a one-month high. AUD/USD preserved recent gains into the Fed decision, sitting around 0.7285, but then was dragged down by the broad USD bounce, slipping under 0.7260. NZD/USD mostly remained elevated, ranging between 0.6770 and 0.6795, but slipping to 0.6750 post-FOMC. AUD/NZD firmed, from 1.0720 to 1.0750." Reported by FXstreet.com 1 hour ago.

    0 0

    OMAHA, Neb., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Werner Enterprises (NASDAQ: WERN), a premier transportation and logistics company, honored military veterans at locations nationwide with Veterans Day ceremonies at its global headquarters in Omaha, Nebraska, and at its terminals in Joliet, Illinois, and Denver, Colorado, on Thursday, Nov. 8.“We will continue our mission to actively support all military veterans, veteran spouses and their families every day within our organization and our communities,” said President and Chief Executive Officer Derek Leathers. “We are proud to have the opportunity to show our appreciation to those who have sacrificed to serve our country.”

    As a military-friendly employer, Werner received the 2018 Secretary of Defense Employer Support Freedom Award, the highest recognition awarded by the Department of Defense, for its support of National Guard and Reserve members. Werner is proud to say that military veterans and veteran spouses comprise approximately 20 percent of its global workforce.  

    Werner Enterprises, Inc. was founded in 1956 and is a premier transportation and logistics company, with coverage throughout North America, Asia, Europe, South America, Africa and Australia. Werner maintains its global headquarters in Omaha, Nebraska and maintains offices in the United States, Canada, Mexico and China. Werner is among the five largest truckload carriers in the United States, with a diversified portfolio of transportation services that includes dedicated; medium-to-long-haul, regional and expedited van; and temperature-controlled. The Werner Logistics portfolio includes truck brokerage, freight management, intermodal, international and final mile services. International services are provided through Werner’s domestic and global subsidiary companies and include ocean, air and ground transportation; freight forwarding; and customs brokerage.

    Werner Enterprises, Inc.’s common stock trades on the NASDAQ Global Select Market^SM under the symbol “WERN.” For further information about Werner, visit the company’s website at www.werner.com.

    Contact: Fred Thayer, Director of Corporate Communications
    Werner Enterprises, Inc.
    402.895.6640 ext. 100-2065
    fthayer@werner.com    Reported by GlobeNewswire 54 minutes ago.

    0 0

    Medicine Man Technologies Reports Record Quarterly Operating Revenue of $4.6M, Quarterly Investment Related Income of $2.6M, and its Third Consecutive Quarter Profit Posting of $4.9M *DENVER, CO / ACCESSWIRE / November 8, 2018 / *Medicine Man Technologies Inc. (OTCQB: MDCL) ("Medicine Man Technologies" or "Company"), one of the United States' leading cannabis branding and consulting companies today provided financial results for the quarter ended September 30, 2018.

    During the three months ending September 30, 2018, the Company generated operating revenues of $4,647,163, an increase of approximately 400% as compared to revenues of $928,264 in the three months ending September 30, 2017. Other income for the three months ending September 30, 2018 increased to $2,605,672 as compared with losses in the three months ending September 30,2017 of . This substantial increase in the Company's overall revenue stream is related to both internal revenue source growth as well as the Company's Canada House Wellness (CHV) Master Licensing Agreement as announced in July of this year.

    The Company reported cost of goods and services totaling $459,280 during the three months ended September 30, 2018. This is compared to $297,185 during the same time period in 2017. The increase is primarily due to an increase in overall product sales volume.

    Operating expenses during the three months ended September 30, 2018, increased by $892,051 to $1,824,876 over the prior period of $950,825, ended September 30, 2017 noting $673,500 of this expense increase was related to stock compensation.

    The Company reported net income related to the three months ending September 30, 2018 of $4,950,679 or $0.18 per share as compared with losses of as related to the three months ending September 30, 2017.

    Year to date total income performance increased dramatically to $9,917,476 for the nine months ending September 30, 2018 as compared to total income of $2,585,479 as reported for the nine months ending September 30, 2017.

    Year to date net income performance increased dramatically to $5,157,717 or $0.19 per share for the nine months ending September 30, 2018 as compared to losses of or per share as reported for the period ending September 30, 2017.

    While the Company continues to grow its organic revenues, the Master Licensing Agreement as noted was responsible for a large portion of this revenue growth however, organic growth still increased to $3,782,921 in the nine months ended September 30, 2018 from $2,485,479 as related to the nine months ended September 30, 2017.

    "We continue to prove out our path to profitability model and demonstrate strong organic as well as one-time revenue growth as we conclude our third consecutive profitable quarter, followed closely by achieving our seventh quarter of consecutive revenue growth," Brett Roper, Medicine Man Technologies' co-founder, and CEO stated. "We are also exploring other globally sourced master license agreement opportunities and are pleased to also acknowledge our Company's move to QX status on the OTC markets as achieved this past September."

    Joshua Haupt, Medicine Man Technologies Chief Operating Officer added, "With this exceptional progress and the lack of any debt, I am very excited about what our future holds as we move into 2019. With our Grow Ohio Pharma client's Zanesville Ohio facility coming online coupled with our Calypso client's Erie Pennsylvania facility planned for operational status in the second quarter of 2019, we have many new opportunities ahead for the Company. I also look forward to attending next week's MJ Business Conference in Las Vegas Nevada and connecting with my many colleagues in the industry."

    Andy Williams, Medicine Man Technologies' Chairperson of the Board stated, "With the Colorado Governorship going to Jared Polis, a seasoned advocate of the cannabis industry and states' rights this provides new momentum for the continuation of the industry's success which has continued to bolster the state's economy, generating record-setting revenue and creating thousands of jobs for the citizens of Colorado. As a result of regulatory advancements made by legislative bodies on the local, federal and international levels, the national cannabis market place continues to expand as further evidenced by this week's election cycle. Medicine Man Technologies' multi-jurisdictional business model has positioned the Company to leverage this dramatic growth nationally setting a clear path to Colorado based public company ownership in 2019."

    *Conference Call Instructions*

    The Company will host a conference call on Friday, November 9, 2018 at 10:30 AM Eastern Time to discuss the results.

    *Participant Dial-In Numbers:*

    *TOLL-FREE 1-* *877-407-9716*

    *TOLL/INTERNATIONAL 1-201-493-6779*

    *Participants should request the Medicine Man earnings call or provide confirmation code 13684963.*

    Investors are invited to listen via webcast available on the Medicine Man Technologies investor section of the Company's website at http://www.medicinemantechnologies.com/investor-calendar.html. Please visit the website 15 minutes prior to the call to register, download, and install any necessary audio software. For interested individuals unable to join the conference call, a replay of the call will be available through November 23, 2018, at 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 13684963. The online archive of the webcast will be available on the investor section of the Company's website for 30 days following the call.

    Brett Roper, Co-Founder and Chief Executive Officer of Medicine Man Technologies, and Jonathan Sandberg, Chief Financial Officer, will be answering shareholder questions at the conclusion of the call. Should you have questions prior to the conference call please send an email to MDCL@kcsa.com with 'MDCL Question' in the subject line. Management will answer as many questions as time will allow.

    *About Medicine Man Technologies, Inc.*

    Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Oklahoma, Missouri, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. We continue to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will "share" the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

    *Safe Harbor Statement*

    This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based on many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in the expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long-term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

    To be added to the Medicine Man email distribution list, please email, MDCL@kcsa.com with MDCL in the subject line.

    For more information, visit us at *www.medicinemantechnologies.com**;**www.threealight.com*

    *Contact Information:*

    Brett Roper via
    info@medicinemantechnologies.com
    Telephone (303) 371-0387

    *MEDICINE MAN TECHNOLOGIES, INC.
    CONSOLIDATED BALANCE SHEETS*
    Expressed in U.S. Dollars *September 30, 2018* *December 31, 2017*


    *Assets*
    Current assets

    Cash and cash equivalents
    $ 529,674 $ 748,715
    Accounts receivable
    1,009,170 461,343
    Accounts receivable - related party
    53,839 25,719
    Litigation receivable
    990,864 -
    Short-term note receivable, net of allowance
    188,550 191,111
    Inventory
    441,960 106,091
    Other assets
    34,582 42,819
    Total current assets
    3,248,639 1,575,798


    Non-current assets

    Fixed assets, net accumulated depreciation of $131,405 and $82,038
    $ 84,493 $ 150,047
    Intangible assets, net accumulated amortization of $12,275 and $7,388
    82,825 87,712
    Goodwill
    12,304,306 9,304,306
    Investment
    5,260,840 -
    Other non-current assets
    26,317 14,500
    Total non-current assets
    17,758,781 9,556,565


    Total assets
    $ 21,007,420 $ 11,132,363


    *Liabilities and Stockholders' Equity*



    Current liabilities

    Accounts payable
    $ 172,360 $ 123,251
    Accounts payable - related party
    53,000 155,177
    Accrued expenses
    47,684 -
    Other liabilities
    - 56,495
    Total current liabilities
    273,044 334,923


    Long-term liabilities

    Note payable - related party
    $ - $ 58,280
    Total long-term liabilities
    - 58,280


    Total liabilities
    273,044 393,203


    Commitments and contingencies, note 13

    Shareholders' equity

    Common stock $0.001 par value. 90,000,000 authorized, 27,578,310 and 22,991,137 were issued and outstanding September 30, 2018 and December 31, 2017, respectively
    $ 28,766 $ 23,113
    Additional paid-in capital
    20,283,174 13,997,441
    Additional paid-in capital - Warrants
    2,054,369 3,508,256
    Accumulated other comprehensive (loss)
    - -
    Retained earnings
    (1,631,933 ) (6,789,650 )
    Total shareholders' equity (deficit)
    20,734,376 10,739,160


    Total liabilities and stockholders' equity
    $ 21,007,420 $ 11,132,363

    *MEDICINE MAN TECHNOLOGIES, INC.
    CONSOLIDATED STATEMENT OF COMPREHENSIVE (LOSS) AND INCOME *
    For the Three and Nine Months Ended September 30, 2018 and 2017
    Expressed in U.S. Dollars *Three Months Ended September 30,* *Nine Months Ended September 30,*

    *2018* *2017* *2018* *2017*


    *Operating revenues*

    Product sales, net
    $ 280,737 $ 278,495 $ 797,381 $ 506,900
    Product sales - related party, net
    143,761 61,768 425,499 184,711
    Litigation revenue
    180,000 - 1,015,154 -
    Cultivation Max
    88,933 - 304,090 -
    Master licensing fees
    3,518,322 - 3,518,322 -
    Licensing fees
    237,700 347,504 663,414 848,816
    Consulting fees
    163,147 238,480 486,747 805,086
    Reimbursements
    29,840 - 72,920 -
    Services - related party
    4,479 - 13,437 -
    Seminars and others
    244 2,017 4,279 6,239
    Total revenue
    4,647,163 928,264 7,301,243 2,351,752


    *Cost of goods and services*

    Cost of goods and services
    $ 421,055 $ 282,894 $ 1,091,386 $ 694,018
    Cost of goods and services - related party
    38,225 14,291 121,808 40,327
    Total cost of goods and services
    459,280 297,185 1,213,194 734,345


    *Gross profit*
    $ 4,187,883 $ 631,079 $ 6,088,049 $ 1,617,407


    *Operating expenses*

    General and administrative
    $ 170,117 $ 331,764 $ 417,467 $ 735,018
    Professional services
    177,103 144,796 657,694 384,278
    Acquisition costs
    - 42,600 - 141,301
    Stock based compensation expenses
    837,500 164,000 837,500 4,644,318
    Officers and directors bonuses
    145,104 90,823 196,157 90,823
    Advertising
    32,110 49,592 109,650 136,436
    Conference and travel expenses
    57,595 - 183,530 -
    Salaries
    423,347 127,250 1,144,567 220,365
    Total operating expenses
    $ 1,842,876 $ 950,825 $ 3,546,565 $ 6,352,539


    *Income from operations*
    $ 2,345,007 $ (319,746 ) $ 2,541,484 $ (4,735,132 )


    *Other income/expense*

    Interest (income)
    $ (7,562 ) $ (7,562 ) $ (22,439 ) $ (22,439 )
    Net loss on derivative liability
    - 136,088 - 4,706
    Interest expense related to convertible notes
    - 22,636 - 66,965
    Loss on sales of assets
    - - 4,316 -
    Loss on management fee contracts
    - - - 70,257
    Net loss on available for sale securities
    - 14,719 - 14,457
    Unrealized (gain)/loss on investments
    (2,598,110 ) - (2,598,110 ) (219 )
    Total other expense
    (2,605,672 ) 165,881 (2,616,233 ) 133,727


    *Net (loss) income*
    $ 4,950,679 $ (485,627 ) $ 5,157,717 $ (4,868,859 )


    *Earnings per share attributable to common shareholders:*

    Basic and diluted (loss)/earnings per share
    $ 0.18 $ (0.02 ) $ 0.19 $ (0.22 )
    Weighted average number of shares outstanding - basic and diluted
    27,578,310 21,883,853 27,578,310 21,883,853


    Other comprehensive (loss), net of tax

    Net unrealized (loss) on available for sale securities
    - - - -
    Total other comprehensive income (loss), net of tax
    - - - -


    *Comprehensive (loss) gain*
    $ 4,950,679 $ (485,627 ) $ 5,157,717 $ (4,868,859 )

    *MEDICINE MAN TECHNOLOGIES, INC.
    CONSOLIDATED STATEMENTS OF CASH FLOWS*
    For the Nine Months Ended September 30, 2018 and 2017
    Expressed in U.S. Dollars *2018* *2017*
    *Cash flows from operating activities*

    Net income for the period
    $ 5,157,717 $ (4,868,859 )
    Adjustments to reconcile net income to net cash provided by operating activities

    Loss (gain) on investment, net
    - 4,706
    Stock based compensation
    837,500 4,644,318
    Depreciation and amortization
    54,253 43,650
    Changes in operating assets and liabilities

    Proceeds from note receivable
    2,561 (22,439 )
    Accounts receivable
    (1,566,811 ) (373,902 )
    Inventory
    (335,869 ) (87,685 )
    Other assets
    (3,580 ) (65,331 )
    Accounts payable and other liabilities
    (61,879 ) 68,490
    *Net cash earned (used) from operating activities*
    4,083,892 (637,052 )


    *Cash flows from investing activities*

    Sale of assets
    16,187 (242,685 )
    Short term debt
    (58,280 ) -
    Acquisition investment
    - 233,357
    Investment proceeds
    (5,260,840 ) -
    AFS securities investment, net
    - 4,305
    *Net cash earned from investing activities*
    (5,302,933 ) (5,023 )


    *Cash flows from financing activities*

    Sale of common stock
    1,000,000 1,058,658
    Cash raised by sale of convertible debt
    - 179,777
    *Net cash earned from financing activities*
    1,000,000 1,238,435


    Net decrease in cash and cash equivalents
    (219,041 ) 576,360
    Cash and cash equivalents - beginning of period
    748,715 351,524
    *Cash and cash equivalents - end of period*
    $ 529,674 $ 927,884

    *SOURCE:* Medicine Man Technologies Inc.
    View source version on accesswire.com:
    https://www.accesswire.com/527570/Medicine-Man-Technologies-Reports-Record-Quarterly-Operating-Revenue-of-46M-Quarterly-Investment-Related-Income-of-26M-and-its-Third-Consecutive-Quarter-Profit-Posting-of-49M Reported by Accesswire 32 minutes ago.

    0 0

    Australia and Indonesia were expected to finalise a major trade deal at ASEAN next week, but the government’s potential embassy move in Israel may have soured relations with Jakarta. Reported by SBS 26 minutes ago.

    0 0

    Australia and Indonesia were expected to finalise a major trade deal at ASEAN next week, but the government’s potential embassy move in Israel may have soured relations with Jakarta. Reported by SBS 20 minutes ago.

    0 0

    Shanina Shaik and Georgia Fowler get ready backstage at the Victoria's Secret Fashion Show There are a handful of models representing Australia and New Zealand at this year's Victoria's Secret Fashion Show in New York City. Reported by MailOnline 6 minutes ago.

    0 0

    Who Gives A Crap introduces limited-edition “Happy” designs for its 2018 holiday collection

    NEW YORK (PRWEB) November 08, 2018

    Who Gives A Crap is launching its new holiday toilet paper designs for a limited time only in an effort to spread holiday cheer after one tough year. Available on November 8th and sold globally, this seasons gifters can purchase a fun, meaningful and unique present for loved ones.

    Who Gives A Crap toilet paper is made with 100% bamboo (super sustainable) and doesn’t contain any inks, dyes or scents to be kind to people’s bums and to mother nature. Who Gives A Crap also gives 50% of profits to help build toilets in developing countries, and has donated over $1.3M to-date.

    Packaged and sent with eight joyful designs, one of which is a gift roll with a “to/from” tag attached, gift recipients are almost guaranteed happiness with prints including fuzzy llamas, favorite holiday treats like ham and turkey (and tofurkey!), and even sample letters to Santa. Each thoughtful design was illustrated by renowned artist, Ruby Taylor, a UK-based designer known for bringing smiles to people’s faces through her creations.

    As if this all wasn’t enough, the Who Gives A Crap team also decided to take it one step further with their packaging this year. For those really looking to help limit the amount of trees cut down each day (did you know making traditional TP wipes out 27,000 trees a day?!), the cardboard box that ships this eco-friendly TP is printed with a pine-needle texture with dotted lines to craft into your very own cardboard tree, wreath and mistletoe.

    “Considering that our business is built on making people smile and ensuring every trip to the bathroom is a delightful experience, we thought this was the perfect year to really focus our designs on making people feel happy.” commented Danny Alexander, co-founder, Who Gives A Crap. “Of course we also focus on encouraging people to stop wiping with trees, so the holiday season is a great time to generate more awareness around the benefits of bamboo TP and the importance of giving back by simply gifting a loved one with something fun, and useful.”

    The “Happy Edition” bamboo toilet paper can be purchased for $55 for 48 jumbo rolls at WhoGivesaCrap.org starting November 8th.

    For more information about Who Gives a Crap, its “Happy” holiday edition, and its mission, please contact PR representative Kristen Mondshein at kristen(at)kmmcommunications.com.

    ENDS

    About Who Gives a Crap
    We love toilet paper because for us, it's our way of making a difference. We started Who Gives A Crap when we learned that 2.3 billion people across the world don't have access to a toilet. That's roughly 40% of the global population and means that around 289,000 children under five die every year from diarrheal diseases caused by poor water and sanitation. That's almost 800 children per day, or one child every two minutes.

    We thought that was pretty crap. So in July 2012, Simon, Jehan and Danny launched Who Gives A Crap with a crowdfunding campaign on IndieGoGo. Simon sat on a toilet in our draughty warehouse and refused to move until we had raised enough pre-orders to start production. 50 hours and one cold bottom later, we'd raised over $50,000.

    We delivered our first product in March 2013 and have been thrilled to keep growing ever since. Not just because our toilet paper is gracing bathrooms across the country but also because we donate 50% of our profits to help build toilets and improve sanitation in the developing world. We’re thrilled to say that we’ve now donated over $1.3million to help build toilets!

    We now distribute Who Gives A Crap in the US, UK, Australia and a few dozen other countries throughout Europe,Though we're still growing, and now make more than just toilet paper, we always want to stay true to our roots: toilet humor and making the world a better place. Reported by PRWeb 17 minutes ago.

    0 0

    FLEMINGTON, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its fiscal 2018 third quarter ended September 30, 2018.For the three months ended September 30, 2018, HCCC generated revenue of $1,839,491 and a net loss of $267,328, or ($0.04) in earnings per share fully diluted, which includes $69,199 in non-cash charges. For the nine months ended September 30, 2018, HCCC generated revenue of $5,575,640 and a net loss of $364,342, or ($0.05) in earnings per share fully diluted, which includes $200,848 in non-cash charges. As of September 30, 2018, HCCC has submitted overall proposals in the amount of $12,751,061 and had a backlog of projects to complete totaling $715,595. The balance sheet as of September 30, 2018 remained solid with $331,236 in cash, $3,548,607 in assets and $417,338 in working capital.

    Andrew Hidalgo, CEO of HCCC, commented, "In the third quarter, we committed to investing in the expansion of the renewable energy effort at our Pride Group subsidiary in Australia, which resulted in significant capital expenditures in labor, training and business development. We believe this investment will be the key to launching our renewable energy efforts in the Asia-Pacific region as we are currently quoting many projects in a very active market. Further, our PVBJ subsidiary had a higher level of material purchases in the third quarter for projects to be completed in the fourth quarter. In addition to the capital expenditures for growth initiatives, we absorbed non-cash charges in the third quarter and the year-to-date financials for compliance purposes. Non-cash charges do not affect the cash flow performance or working capital of HCCC. Our subsidiaries are performing well exclusive of these corporate expenses. We have recently initiated several hydrogen energy projects and combined with our continued investments in expanding the renewable energy market effort, we are very encouraged about the future quarters. HCCC continues to build momentum by training our existing subsidiaries in clean energy, identifying many new opportunities and expanding our customer base. We look forward to future growth and building shareholder value.”

    About H/Cell Energy Corporation:

    H/Cell Energy Corporation is an integrator that focuses on the design and implementation of clean energy solutions including solar, battery, fuel cell and hydrogen generation systems. In addition, through its subsidiaries, HCCC also provides environmental systems and security systems integration. HCCC serves the residential, commercial and government sectors. Please visit our website at www.hcellenergy.com for more information.

    Forward Looking Statements:

    Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on current expectations and actual results could differ materially. H/Cell Energy Corporation does not undertake an obligation to update or revise any forward-looking statement. The information set forth herein speaks only as of the date hereof.

    H/Cell Energy Corporation
    Investor Relations
    908-837-9097 x-2

     
    *H/CELL ENERGY CORPORATION*
    *CONDENSED CONSOLIDATED BALANCE SHEETS*
             
        *September 30, 2018*   *December 31, 2017*
        *(Unaudited)*   *(Audited)*
    * ASSETS *        
    Current assets        
    Cash and cash equivalents   $ 331,236     $ 455,700  
    Accounts receivable (net retention)     1,230,621       808,050  
    Prepaid expenses     23,282       14,669  
    Costs and earnings in excess of billings     73,180       51,531  
    Total current assets     1,658,319       1,329,950  
             
    Property and equipment, net     362,933       102,573  
    Security deposits and other non-current assets     20,711       8,416  
    Deferred tax asset     44,257       44,257  
    Customer lists, net     88,766       -  
    Goodwill     1,373,621       -  
             
    *Total assets *   $ 3,548,607     $ 1,485,196  
             
    * LIABILITIES AND STOCKHOLDERS' EQUITY *        
             
    Current liabilities        
    Accounts payable and accrued expenses   $ 830,708     $ 631,385  
    Management fees payable – related party     -       31,257  
    Earn-out payable     186,346       -  
    Billings in excess of costs and earnings     51,798       87,206  
    Sales and withholding tax payable     45,154       61,239  
    Current equipment notes payable     32,538       -  
    Current capital lease payable     68,240       -  
    Income tax payable     26,197       98,313  
    *Total current liabilities *     1,240,981       909,400  
             
    Noncurrent liabilities        
    Note payable     222,963       -  
    Capital leases     149,590       -  
    Equipment notes payable     118,606       -  
    Convertible note payable – related party, net of discount     14,268       -  
    *Total noncurrent liabilities*     505,427       -  
             
    *Total liabilities*     1,746,408       909,400  
             
    *Commitments and contingencies  *   * *    
             
    *Stockholders' equity *        
    Preferred stock - $0.0001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding     -       -  
    Common stock - $0.0001 par value; 25,000,000 shares authorized; 7,586,024 and 7,041,579 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively     758       704  
    Additional paid-in capital     2,967,004       1,335,656  
    Accumulated deficit     (1,096,096 )     (731,754 )
    Accumulated other comprehensive loss     (69,467 )     (28,810 )
    *Total stockholders' equity *     1,802,199     $ 575,796  
    * *        
    *TOTAL LIABILITIES & STOCKHOLDERS' EQUITY *   $ 3,548,607     $ 1,485,196  
                     

    The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

     
    *H/CELL ENERGY CORPORATION*
    *CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS – OTHER COMPREHENSIVE INCOME*
             
        *For the Three Months
    Ended September 30,*   *For the Nine Months *
    *Ended September 30,*
        *2018*   *2017*   *2018*   *2017*
                     
    *Revenue *                
    Construction income   $ 1,830,992     $ 1,292,905     $ 5,535,352     $ 5,050,155
    Related party     8,499       45,666       40,288       85,919
    *Total revenue *     1,839,491       1,338,571       5,575,640       5,136,074
                     
    *Cost of goods sold *                
    Direct costs     1,438,669       870,369       3,901,125       3,432,098
    Direct costs – related party     9,019       37,304       40,636       87,649
    *Total cost of goods sold *     1,447,688       907,673       3,941,761       3,519,747
                     
    *Gross profit *     391,803       430,898       1,633,879       1,616,327
                     
    *Operating expenses *                
    General and administrative expenses     607,125       437,344       1,850,140       1,379,415
    Management fees – related party     19,500       46,000       58,500       138,000
    *Total operating expenses *     626,625       483,344       1,908,640       1,517,415
                     
    *Income (loss) from operations*     (234,822 )     (52,446 )     (274,761 )     98,912
    *Income tax provision (benefit)*     -       -       -       -
    * *                
    *Income (loss) before other income and expense*     (234,822 )     (52,446 )     (274,761 )     98,912
                     
    *Other expenses*                
    Interest expense     7,544       -       21,636       -
    Interest expense – related party     19,877       -       52,768       -
    Change in fair value earn-out     4,290       -       11,028       -
    Loss on fixed asset disposal     795       -       4,149       -
    *Total other expenses*     28,216       -       78,553       -
                     
    *Net income (loss) *   $ (267,328 )   $ (52,446 )   $ (364,342 )   $ 98,912
    * *                
    *Other comprehensive income (loss), net *                
    * *                
    *Foreign currency translation adjustment*     (7,828 )     5,928       (40,657 )     24,345
    * *                
    *Comprehensive income (loss) *   $ (275,156 )   $ (46,518 )   $ (404,999 )   $ 123,257
    * *                
    *Earnings (loss) per share *                
    Basic   $ (0.04 )   $ (0.01 )   $ (0.05 )   $ 0.02
    Diluted   $ (0.04 )   $ (0.01 )   $ (0.05 )   $ 0.01
    *Weighted average common shares outstanding *                
    Basic     7,586,024       7,084,436       7,469,307       6,601,873
    Diluted     7,586,024       7,084,436       7,469,307       7,526,763
                                    Reported by GlobeNewswire 4 minutes ago.

    0 0

    EDEN PRAIRIE, Minn., Nov. 09, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) today announced that on November 8, 2018, the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering into employment with the Company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.In connection with entering into employment with CHF Solutions, the four individuals, who were not previously employees or directors of CHF Solutions, received options to purchase an aggregate of 15,500 shares of the Company’s common stock. The option awards have an exercise price of $1.12 per share, the closing price of CHF Solution’s common stock on November 8, 2018, the date of the grant. The options have ten-year terms and vest over a period of four years, with 25% vesting one year after the date of grant and the remaining 75% vesting in 36 approximately equal monthly increments, provided the new hire’s employment is continuing on each such date, and subject to acceleration or forfeiture upon the occurrence of certain events as set forth in the new hire’s option agreement.

    *About CHF Solutions*

    CHF Solutions, Inc. (Nasdaq:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow® system for aquapheresis therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

    *CONTACTS:*

    *INVESTORS:
    *Claudia Napal Drayton
    Chief Financial Officer
    CHF Solutions, Inc.
    952-345-4205
    ir@chf-solutions.com
    -or-
    Bret Shapiro
    Managing Partner
    CORE IR
    516-222-2560
    brets@coreir.com  
    www.coreir.com   *MEDIA
    *Jules Abraham
    JQA Partners, Inc.
    917-885-7378
    jabraham@jqapartners.com Reported by GlobeNewswire 5 hours ago.

    0 0

    Goliath has acquired MacDue, one of the top ten companies in the Italian toy market with strong brands such as Bburago, Maisto, and Polistil. Goliath, a global leader in the toy and game industry, has decided to invest strategically on the Italian market, relying on the distribution expertise of MacDue Spa, a company with a history of toy and game distribution for over 40 years.

    VILLASANTA, Italy and HATTEM, The Netherlands (PRWEB) November 09, 2018

    Goliath and MacDue are pleased to announce their cooperation for the Italian market. Goliath, a global leader in the toy and game industry, has decided to invest strategically on the Italian market, relying on the distribution expertise of MacDue Spa, a company with a history of toy & game distribution for over 40 years.

    “We are delighted to welcome MacDue’s team to the Goliath family. Having done business together already for many years, they are an excellent fit for us, similar family business principles and with already many products that we also sell in the rest of the world. With our recent acquisitions and European success, it made perfect sense to take this step,” said Adi Golad, founder of Goliath. MacDue, currently the exclusive distributor for Italy of the Maisto, Bburago, Polistil and Rubik's brands, will support the launching of Goliath Italy in the distribution of the vast Goliath portfolio - including Otto il Maialotto, Mr Ficcanaso, Acchiappa il Coniglio, Triominos, Sequence, Rubik's Cube and “Essere o non Essere”.

    "We are grateful to Goliath for believing in the professionality and great experience of MacDue and also honored to welcome and support this great company that has decided to invest in our country," said Andrea Anelli and Paola Gravati. "We immediately found shared objectives, the same principles and values, we are committed to operate with efficiency immediately."

    Supported by a full marketing campaigns, including major TV support, digital marketing and social media straight away, Goliath Italy aims for a Top 10 place on the market in 2019 The Goliath booth in Nuremberg Toy Fair and the new showroom in Villasanta (MB) will be opened for all the customers that want to discover the Goliath world.

    About Goliath
    Goliath was founded in 1980 and is one of the few remaining family-owned global toy and game companies. Goliath is an international manufacturer and distributor of a broad range of products. Examples include Wahu®, Rummikub®, Sequence™, Phlat Ball®, Rubik’s Cube®, Tri-Ominos®, Wordsearch™, Pop the Pig®, Doggie Doo™, Gooey Looey™ and Catch the Fox™. The company has continued to see substantial growth with the acquisitions of Pressman Toy®, JAX®, Tucker Toys® in the US, Crown & Andrews® and Britz ‘n Pieces/Wahu in Australia, Modelco® in France, and Elephanta® in New Zealand. Goliath is a market leader in TV-promoted games and is active in many other toy categories, such as puzzles, arts & crafts, outdoor, activity, and novelties. Goliath products now sell in more than 75 countries worldwide and the company has offices in the Netherlands, Belgium, France, Spain, Portugal, Germany, Poland, Hong Kong, Australia, New Zealand, USA and Canada. Further information is available at http://www.goliathgames.com

    About Mac Due
    MacDue is one of the top ten companies in the Italian toy market. Founded in 1980 by the Anelli family, Mac Due has become an Italian Flag of Distribution specialized in Brand growth. Among the most important brands there are Bburago, Maisto, Polistil, Rubik's brands. The Italian distribution is based on a constant search for new potential channels and on the strength of a superb presence throughout the Italian territory, in all sales channels and in all major key accounts. http://www.macdue.eu Reported by PRWeb 4 hours ago.

    0 0

    Children across Australia are walking out of school to speak with their local federal politicians as they're fed up with inaction on environmental issues. Reported by SBS 4 hours ago.

    0 0

    Josh Adams: Wales wing swaps fan seat for a starting spot v Australia BBC Local News: South West Wales -- Josh Adams watched Wales play Australia as a fan last year. On Saturday, he will be on Wales' left wing at the Principality Stadium. Reported by BBC Local News 4 hours ago.

    0 0

    Wales wing Adams swaps fan seat for a starting spot Josh Adams watched Wales play Australia as a fan last year. On Saturday, he will be on Wales' left wing at the Principality Stadium. Reported by BBC Sport 3 hours ago.

    0 0

    Fewer than 30 youngsters stay on Nauru as clinical transfers of asylum seekers and refugees proceed, however many households are nonetheless separated even inside Australia. Remaining week, the Australian govt mentioned it meant to carry all youngsters and their households despatched to Nauru for immigration detention again to Australia prior to the tip of the … Reported by The News Articles 4 hours ago.

    0 0

    HAMILTON, Bermuda, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) announced today that it has signed an agreement with Maiden Holdings, Ltd. (“Maiden”) and Maiden Reinsurance Ltd., a subsidiary of Maiden (“Maiden Re”). Pursuant to the agreement, an Enstar subsidiary would enter into a retrocession agreement to effect a loss portfolio transfer in which the Enstar subsidiary would assume loss reserves of approximately $2.675 billion associated with Maiden Re’s quota share reinsurance contracts with AmTrust Financial Services, Inc. and its subsidiaries. The retrocession will apply to losses arising and/or claims made on or prior to June 30, 2018, and loss reserves assumed will be subject to adjustment for paid losses since such date. The transaction is subject to regulatory approvals and other closing conditions.

    This represents Enstar’s second agreed transaction with Maiden, following the entrance into a definitive agreement in August 2018 to acquire Maiden Reinsurance North America, Inc. That transaction remains subject to regulatory approvals and closing conditions and is expected to be completed in the fourth quarter of 2018. 

    *About Enstar *

    Enstar is a multi-faceted insurance group, with over $15.1 billion in assets, that offers innovative capital release solutions and specialty underwriting capabilities through its network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations. Enstar is a market leader in completing legacy acquisitions, having acquired over 80 companies and portfolios since its formation in 2001. Enstar’s active underwriting businesses include the StarStone group of companies, an A- rated global specialty insurance group with multiple global underwriting platforms, and the Atrium group of companies, which manage and underwrite specialist insurance and reinsurance business for Lloyd’s Syndicate 609. For further information about Enstar, see www.enstargroup.com.

    *Cautionary Statement*

    This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.  In particular, Enstar may not be able to complete the proposed transaction on the terms summarized above or other acceptable terms, or at all, due to a number of factors, including but not limited to the failure to obtain governmental and regulatory approvals or to satisfy other closing conditions.  Additional important risk factors regarding Enstar can be found under the heading "Risk Factors" in Enstar's Form 10-K for the year ended December 31, 2017 and are incorporated herein by reference. Furthermore, Enstar undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements, except as required by law.

    *Contact:*  Guy Bowker
    *Telephone:*  +1 (441) 292-3645 Reported by GlobeNewswire 3 hours ago.

    0 0

    'I haven't beaten them enough in the red of Wales': Alun Wyn Jones eager to end hoodoo vs Australia  The world had no idea what Uber, Instagram, iPads, Airbnb and WhatsApp were the last time Wales beat Australia. A lot has changed since 2008. Reported by MailOnline 2 hours ago.

    0 0

    ICC Women's World Twenty20: Australia thrash Pakistan by 52 runs Australia beat Pakistan by 52 runs and India defeat New Zealand by 34 runs on the opening day of the ICC Women's World Twenty20. Reported by BBC Sport 3 hours ago.

older | 1 | .... | 1393 | 1394 | (Page 1395) | 1396 | 1397 | .... | 1460 | newer